Adrenal rather than central dysfunction limits HPA axis recovery after chronic glucocorticoid treatment in male mice
Preprint
Abstract
Glucocorticoid-induced adrenal insufficiency (GIAI) can persist for months after discontinuation of chronic corticosteroid therapy, placing patients at risk for life-threatening adrenal crises. This prolonged suppression has been attributed primarily to delayed restoration of hypothalamic–pituitary signaling based on indirect measures of central axis activity. To identify the rate-limiting site of hypothalamic-pituitary-adrenal (HPA) axis recovery, we evaluated the timing of functional and histologic recovery at each node of the axis following 8 weeks of dexamethasone (DEX) treatment in adult, male mice. DEX administration fully suppressed HPA axis activity. Unexpectedly, within one week of DEX withdrawal, hypothalamic Crh mRNA and plasma ACTH rebounded above control levels, whereas corticosterone (CORT) remained suppressed for an additional seven weeks. DEX-treated adrenals were markedly atrophic and contained large clusters of lipid-filled macrophages. Even after adjusting for macrophage content, CORT secretion was disproportionately low relative to the remaining adrenocortical cell mass despite supraphysiologic ACTH stimulation. The adrenal is thus the principal site of post-withdrawal GIAI, involving adrenocortical cell loss and a superimposed defect in steroidogenesis. We next tested whether preserving adrenal trophic signaling during glucocorticoid exposure could prevent GIAI. Adrenal function recovered more slowly in mice treated with DEX and daily cosyntropin (a synthetic ACTH analog) compared to those treated with DEX alone. In contrast, mice with non-suppressible endogenous ACTH due to targeted hypothalamic deletion of the glucocorticoid receptor maintained normal adrenal architecture and steroidogenic capacity despite prolonged DEX treatment. Pharmacologic treatments that mimic sustained trophic signaling to the adrenal during chronic glucocorticoid treatment may thus prevent GIAI.Keywords
Funding Information
- Boston Children's Hospital (Office of Faculty Development/Basic & Clinical Translational Research Executive Committees Faculty Career Development Fellowship)
- Pediatric Endocrine Society (Resarch Fellowship Award)
- Pediatric Endocrine Society (1K08DK142004-01A1)
This publication has 74 references indexed in Scilit:
- Unravelling the sex-specific diversity and functions of adrenal gland macrophagesCell Reports, 2022
- Gender differences in human adrenal cortex and its disordersMolecular and Cellular Endocrinology, 2021
- Stem cell function and plasticity in the normal physiology of the adrenal cortexMolecular and Cellular Endocrinology, 2020
- Prolonged treatment with the synthetic glucocorticoid methylprednisolone affects adrenal steroidogenic function and response to inflammatory stress in the ratBrain, Behavior, and Immunity, 2020
- The Adult Adrenal Cortex Undergoes Rapid Tissue Renewal in a Sex-Specific MannerCell Stem Cell, 2019
- Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndromeEndocrine, 2016
- Prevalence of oral glucocorticoid usage in the United States: A general population perspectiveArthritis Care & Research, 2012
- Endogenous biotin as a marker of adrenocortical cells with steroidogenic potentialMolecular and Cellular Endocrinology, 2011
- Cosyntropin2007
- Adrenocortical cell deletion: The role of ACTHThe Journal of Pathology, 1973